Search

1240993
1240861
1230819
1195994
393884
Primary Analysis results from M72/AS01E vaccine trial
In a a multicenter, double-blind, randomised, placebo-controlled trial conducted in three African countries in which tuberculosis is endemic (Kenya, South Africa, and Zambia), the M72/AS01E TB vaccine provided 54.0% protection for M. tuberculosis–...
Social Reponsiveness
Established in 2001, the South African Tuberculosis Vaccine Initiative (SATVI) was presented with the University of Cape Town’s (UCT) 2018 Social Responsiveness Award at the Faculty of Health Sciences graduation ceremony on Saturday, 13 April 2019
2018 Tb under the Spotlight Science Engagement
The “TB Under the Spotlight Science Engagement” programme was conceptualised and presented by South African Tuberculosis Vaccine Initiative (SATVI) with scientists from the Division of Molecular Biology and Human Genetics at Stellenbosch University...
Biomarker discovery offers hope for new TB vaccine development
A team of scientists from the University of Cape Town, Oxford University and the London School of Hygiene & Tropical Medicine have made a discovery that reveals how we can improve development of more effective vaccines against tuberculosis.
Community Engagement
Carina's Choice: SATVI collaborated with UCT Drama Department and Worcester Secondary School in developing this play which was performed by learners from Worcester Secondary School at 8 local high schools reaching approximately 8 000 adolescents in...

News

Thursday, 22 August 2019
31 May 2019 Latest Research Moving tuberculosis vaccines from theory to practice

Professor Tom Scriba has co-authored a paper titled: "Moving tuberculosis vaccines from theory to practice" appearing in the Nature Reviews Immunology Journal.  

Publication Date:
Fri, 31 May 2019 - 14:45
16 April 2019 Latest Research: Discovery and validation of a prognostic proteomic signature for tuberculosis progression: A prospective cohort study

SATVI authors Drs. Adam Penn-Nicholson, Stanley Kimbung Mbandi, Michelle Fisher, Professors Mark Hatherill and Tom Scriba have co-authored a paper titled "Discovery and validation of a prognostic proteomic signature for tuberculosis progression: A prospective cohort study" appearing in the Plos Medicine journal. 

Publication Date:
Wed, 17 Apr 2019 - 08:15
14 April 2019 SATVI wins Social Responsiveness Award

University of Cape Vice Chancellor, Professor Mamokgethi Phakeng announced the South African Tuberculosis Vaccine Initiative (SATVI) as the winner of the 2018 Vice Chancellor Social Responsiveness Award during the April 2019 Health Faculty Sciences graduation. 

Publication Date:
Sun, 14 Apr 2019 - 19:45
25 March 2019 World TB Day 3 Peaks Challenge

For World TB Day 2019 (24 March 2019) the South African Tuberculosis Vaccine Initiative (SATVI) team tackled the World TB Day Three Peaks Challenge which entailed ascending up Devils Peak, Platteklip Gorge and Lions Head in one day, in a bid to raise awareness about Tuberculosis. 

Publication Date:
Mon, 25 Mar 2019 - 21:00

Pages